Bristol-Myers (BMY) Extends Tender Offer for Medarex (MEDX) to August 26
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
The tender offer that was originally scheduled to expire at 12:00 midnight (New York City time) on August 24, 2009 was extended, with the consent of Medarex, in connection with the parties reaching an agreement in principle to settle the legal proceedings pending in connection with the tender offer. All other terms and conditions of the tender offer remain unchanged.
The tender offer that was originally scheduled to expire at 12:00 midnight (New York City time) on August 24, 2009 was extended, with the consent of Medarex, in connection with the parties reaching an agreement in principle to settle the legal proceedings pending in connection with the tender offer. All other terms and conditions of the tender offer remain unchanged.
You May Also Be Interested In
- Patriot Coal (PCX) CEO Whiting Issues Employee Letter
- BofA Identified as Biggest 'Shark' in JPMorgan Trading Loss Which Could Reach $7B
- Anglo American (AAUKY) will suspend its legal proceedings with Codelco in Chile
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
